Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Skyrizi 75 mg solution for injection in pre-filled syringe

Discontinued
Active Ingredient:
risankizumab
Company:  
AbbVie Ltd See contact details
ATC code: 
L04AC18
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 07 Oct 2024
{pdf} View or print the patient leaflet as PDF
AbbVie Ltd
Company image
Address
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
Telephone
+44 (0)1628 561 092
Medical Information e-mail
[email protected]
Out of Hours Telephone
+44 (0)1628 561 092
WWW
www.abbviemedinfo.com
WWW
www.abbvie.co.uk
Stock Availability
[email protected]
Stock Availability
0800 783 1699